Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | hydroxyprostaglandin dehydrogenase 15-(NAD) | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | steroid dehydrogenase, putative | hydroxyprostaglandin dehydrogenase 15-(NAD) | 266 aa | 216 aa | 22.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0083 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.7568 | 0.7568 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0028 | 0.161 | 0.0328 |
Loa Loa (eye worm) | RNA binding protein | 0.0067 | 0.7568 | 0.7568 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0048 | 0.4687 | 0.4687 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0048 | 0.4687 | 0.4687 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 CLPP1 (ENDOPEPTIDASE CLP) | 0.0054 | 0.559 | 0.4744 |
Schistosoma mansoni | chromobox protein | 0.0074 | 0.8604 | 0.8604 |
Echinococcus granulosus | peptidase Clp S14 family | 0.0054 | 0.559 | 0.559 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0067 | 0.7568 | 0.7568 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0083 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.3592 | 0.2714 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.605 | 0.605 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.7568 | 0.7568 |
Brugia malayi | hypothetical protein | 0.0027 | 0.1325 | 0.1325 |
Brugia malayi | RNA binding protein | 0.0067 | 0.7568 | 0.7568 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.0083 | 1 | 1 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0083 | 1 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0039 | 0.325 | 0.325 |
Schistosoma mansoni | hypothetical protein | 0.0039 | 0.325 | 0.325 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0067 | 0.7568 | 0.7568 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.1325 | 0.5 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 1 ClpP1 (endopeptidase CLP) | 0.0054 | 0.559 | 0.5 |
Brugia malayi | chromobox protein homolog 3 | 0.0041 | 0.3592 | 0.3592 |
Trichomonas vaginalis | chromobox protein, putative | 0.0044 | 0.4078 | 0.3419 |
Loa Loa (eye worm) | TAR-binding protein | 0.0067 | 0.7568 | 0.7568 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0083 | 1 | 1 |
Echinococcus granulosus | chromobox protein 1 | 0.0074 | 0.8604 | 0.8604 |
Echinococcus multilocularis | tar DNA binding protein | 0.0067 | 0.7568 | 0.7568 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0083 | 1 | 0.5 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0044 | 0.4078 | 1 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0083 | 1 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0027 | 0.1325 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0057 | 0.605 | 0.605 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.2211 | 0.2211 |
Brugia malayi | Heterochromatin protein 1 | 0.0074 | 0.8604 | 0.8604 |
Leishmania major | hypothetical protein, conserved | 0.0027 | 0.1325 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0067 | 0.7568 | 0.7568 |
Trichomonas vaginalis | chromobox protein, putative | 0.0074 | 0.8604 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0044 | 0.4078 | 0.3419 |
Echinococcus granulosus | chromobox protein 1 | 0.0074 | 0.8604 | 0.8604 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.0054 | 0.559 | 0.559 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.1325 | 0.1325 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 2 ClpP2 (endopeptidase CLP 2) | 0.0054 | 0.559 | 0.5 |
Schistosoma mansoni | chromobox protein | 0.0074 | 0.8604 | 0.8604 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0048 | 0.4687 | 0.4687 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0057 | 0.605 | 0.605 |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.0083 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0048 | 0.4687 | 0.4687 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.3592 | 0.3592 |
Echinococcus multilocularis | chromobox protein 1 | 0.0074 | 0.8604 | 0.8604 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0083 | 1 | 1 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0074 | 0.8604 | 0.8604 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0083 | 1 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0074 | 0.8604 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.7568 | 0.7568 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.7568 | 0.7568 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.3592 | 0.2714 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0048 | 0.4687 | 0.4687 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0028 | 0.161 | 0.0328 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0057 | 0.605 | 0.605 |
Echinococcus granulosus | tar DNA binding protein | 0.0067 | 0.7568 | 0.7568 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0083 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.325 | 0.325 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0048 | 0.4687 | 0.4687 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0048 | 0.4687 | 0.4687 |
Toxoplasma gondii | hypothetical protein | 0.0028 | 0.161 | 0.0328 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.0083 | 1 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0048 | 0.4687 | 0.4687 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.7568 | 0.7568 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.1325 | 0.5 |
Echinococcus multilocularis | chromobox protein 1 | 0.0074 | 0.8604 | 0.8604 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0083 | 1 | 1 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0041 | 0.3592 | 0.7399 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0048 | 0.4687 | 0.4687 |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.0083 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.8526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.